BUFFALO — The U.S. Drug Enforcement Administration’s move to reclassify cannabis from a Schedule I to a Schedule III substance has broad implications, paving the way for more informed research
UB experts weigh in on DEA s reclassification of cannabis wnypapers.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wnypapers.com Daily Mail and Mail on Sunday newspapers.
A growing body of research on cancer and cannabis is a testament to the plant’s many uses. Now, a psychologist at the University at Buffalo is studying the effects of cannabis use in oncology patients who receive immunotherapy, a treatment that helps your immune system fight cancer, resulting in fewer side effects than chemotherapy.
UB researcher receives $3 2 million grant to study impact of cannabis on immunotherapy - UBNow: News and views for UB faculty and staff buffalo.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from buffalo.edu Daily Mail and Mail on Sunday newspapers.